F. Carsten Thiel
Vorstandsvorsitzender bei EUSA Pharma (UK) Ltd.
Aktive Positionen von F. Carsten Thiel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EUSA Pharma (UK) Ltd.
EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Direktor/Vorstandsmitglied | 31.03.2021 | - |
Vorstandsvorsitzender | 31.03.2021 | - |
Karriereverlauf von F. Carsten Thiel
Ehemalige bekannte Positionen von F. Carsten Thiel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KARYOPHARM THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 04.09.2018 | 27.11.2018 |
ABEONA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 10.05.2018 | 26.11.2018 |
Vorstandsvorsitzender | 02.04.2018 | 26.11.2018 | |
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.09.2014 | 01.06.2017 |
AMGEN INC. | Corporate Officer/Principal | 01.01.2011 | 01.01.2014 |
AMGEN GmbH
AMGEN GmbH BiotechnologyHealth Technology AMGEN GmbH develops, manufactures, and markets human therapeutics based on cellular biology. It was established to help sell and distribute biotechnical therapies for the treatment of such ailments as chemotherapy side effects, chronic kidney failure, and rheumatoid arthritis. Among the group's products are Epogen & Aranesp for the treatment of anemia in people with chronic kidney disease; Neupogen & Neulasta to help restore white blood cell counts for cancer patients and Enbrel for the treatment of psoriasis and rheumatoid arthritis. The company was founded in 1980 and is headquartered in Munich, Germany. | Vorstandsvorsitzender | - | - |
Ausbildung von F. Carsten Thiel
Max-Planck-Institute for Molecular Genetics | Doctorate Degree |
Philipps University of Marburg | Graduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Deutschland | 4 |
Vereinigtes Königreich | 2 |
Operativ
Chief Executive Officer | 3 |
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ABEONA THERAPEUTICS INC. | Health Technology |
AMGEN INC. | Health Technology |
KARYOPHARM THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
AMGEN GmbH
AMGEN GmbH BiotechnologyHealth Technology AMGEN GmbH develops, manufactures, and markets human therapeutics based on cellular biology. It was established to help sell and distribute biotechnical therapies for the treatment of such ailments as chemotherapy side effects, chronic kidney failure, and rheumatoid arthritis. Among the group's products are Epogen & Aranesp for the treatment of anemia in people with chronic kidney disease; Neupogen & Neulasta to help restore white blood cell counts for cancer patients and Enbrel for the treatment of psoriasis and rheumatoid arthritis. The company was founded in 1980 and is headquartered in Munich, Germany. | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
EUSA Pharma (UK) Ltd.
EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Distribution Services |
- Börse
- Insiders
- F. Carsten Thiel
- Erfahrung